Reduced Launch Milestone Payment. Within ten (10) business days of Endo's first commercial sale of Licensed Product, Endo shall pay to Noven Seven Million Five Hundred Thousand Dollars ($7,500,000) (the "Reduced Launch Milestone Payment"), if *** or more other generic formulations of Duragesic(R) have been approved or launched, including ***.
Appears in 4 contracts
Samples: License Agreement (Noven Pharmaceuticals Inc), License Agreement (Noven Pharmaceuticals Inc), License Agreement (Endo Pharmaceuticals Holdings Inc)
